How to Get Jatenzo in West Virginia

What Is Jatenzo and Why Does the Route of Administration Matter?

Jatenzo is the brand name for oral testosterone undecanoate, approved by the FDA in March 2019 for adult males with conditions associated with a deficiency or absence of endogenous testosterone. It is the first oral testosterone replacement therapy approved in the United States that bypasses first-pass hepatic metabolism through lymphatic absorption [1]. This matters clinically because older oral androgens like methyltestosterone carried significant hepatotoxicity risk.

In the key trial by Swerdloff et al. (2020), 166 hypogonadal men receiving oral testosterone undecanoate 237 mg twice daily achieved a mean steady-state testosterone concentration (C_avg) of 489 ng/dL at day 90, with 87% of subjects reaching the eugonadal range of 300 to 1,100 ng/dL [2]. The trial also reported that testosterone undecanoate did not produce the supraphysiologic spikes seen with some injectable formulations.

For men in West Virginia who dislike needles or cannot maintain the injection schedules required by testosterone cypionate, Jatenzo offers a twice-daily oral alternative. The capsule must be taken with food containing at least 15 grams of fat per meal to ensure adequate lymphatic uptake, a point many prescribers emphasize during counseling.

Step-by-Step: Getting a Jatenzo Prescription in West Virginia

The process has four stages: lab confirmation, clinical evaluation, prescription, and pharmacy fulfillment. Each stage can be completed without an in-person visit if you use a telehealth provider licensed in the state.

Stage 1: Baseline labs. The Endocrine Society's 2018 clinical practice guideline requires two morning fasting total testosterone measurements below 300 ng/dL on separate days before initiating therapy [3]. Most providers also order a complete metabolic panel, lipid panel, complete blood count with hematocrit, PSA (for men over 40), and LH/FSH to distinguish primary from secondary hypogonadism. Labs can be drawn at any CLIA-certified facility in West Virginia. Quest Diagnostics and LabCorp both operate draw sites across the state, with locations in Charleston, Morgantown, Huntington, and Parkersburg.

Stage 2: Clinical evaluation. A licensed prescriber reviews your labs, symptoms (fatigue, low libido, erectile dysfunction, depressed mood, decreased muscle mass), and medical history. This visit may be synchronous video or asynchronous depending on the platform. West Virginia telehealth law permits the establishment of a prescriber-patient relationship via real-time audio-video communication.

Stage 3: Prescription. Because Jatenzo is a Schedule III controlled substance under the Anabolic Steroids Control Act, the prescription must comply with DEA regulations. West Virginia permits electronic prescribing of controlled substances (EPCS). Your prescriber sends the Rx directly to your chosen pharmacy.

Stage 4: Pharmacy fulfillment. Not every retail pharmacy stocks Jatenzo. Specialty pharmacies and mail-order pharmacies licensed in West Virginia are often the most reliable channel. Expect 3 to 7 business days for delivery if the pharmacy needs to order stock.

Who Can Prescribe Jatenzo in West Virginia?

Three categories of providers hold independent or delegated prescriptive authority for Schedule III substances in West Virginia: physicians (MD/DO), nurse practitioners with full practice authority, and physician assistants practicing under a collaborative agreement.

West Virginia granted full practice authority to nurse practitioners effective July 1, 2016, meaning NPs with the appropriate DEA registration can prescribe Jatenzo without physician co-signature. PAs may prescribe Schedule III drugs under their supervising physician's DEA number or their own mid-level practitioner DEA registration, depending on practice structure. This is relevant in rural parts of the state where NPs and PAs deliver a large share of primary care.

Endocrinologists, urologists, and men's health specialists are the most common prescribers, but any provider comfortable managing testosterone replacement therapy can write the prescription. The American Urological Association's 2018 guideline on testosterone deficiency supports treatment initiation by primary care providers who follow structured monitoring protocols [4].

Telehealth Access for Jatenzo in West Virginia

West Virginia permits telehealth prescribing of controlled substances, including Schedule III drugs like Jatenzo. The state's telehealth parity law (WV Code §30-1-26) requires that the prescriber hold an active West Virginia medical license or multi-state compact license. A provider licensed only in Ohio or Virginia cannot legally prescribe to a patient located in West Virginia at the time of the encounter.

Telehealth platforms that serve West Virginia typically handle lab ordering, clinical evaluation, prescribing, and pharmacy coordination in a single workflow. Some platforms partner with specific specialty pharmacies to reduce fulfillment delays.

One consideration specific to West Virginia: broadband availability. The FCC's 2023 Broadband Progress Report found that approximately 23% of rural West Virginians lacked access to fixed broadband at 25/3 Mbps. If video visits are impractical, some platforms offer audio-only initial consultations where permitted by the provider's clinical judgment. Follow-up monitoring visits, however, typically require video to assess patient-reported outcomes and review labs on screen.

Insurance, Cost, and Prior Authorization in West Virginia

Jatenzo carries a list price of approximately $650 to $750 for a 30-day supply (120 capsules of 158 mg or 237 mg). Cost is the single biggest barrier to access for most patients.

West Virginia Medicaid: Jatenzo is not on the West Virginia Medicaid preferred drug list. Medicaid beneficiaries seeking coverage would need to pursue an exception request, which requires documentation that injectable testosterone formulations failed or are contraindicated. Approval rates for non-preferred brand testosterone products through Medicaid exception pathways are low.

Commercial insurance: Many commercial plans in West Virginia (Highmark, The Health Plan, UniCare) may cover Jatenzo after prior authorization. The PA process typically requires:

• Documented diagnosis of male hypogonadism (ICD-10 E29.1)
• Two serum testosterone levels below 300 ng/dL drawn before 10 AM on separate days
• Documentation of why injectable testosterone is not appropriate (needle phobia, injection site reactions, or documented poor adherence)
• Prescriber attestation that the patient has no contraindications (polycythemia, untreated obstructive sleep apnea, uncontrolled heart failure)

PA turnaround in West Virginia averages 5 to 15 business days. If denied, you may file a formal appeal. Some patients bypass insurance entirely and use the Jatenzo Savings Program, which can reduce out-of-pocket cost to as low as $75 per month for commercially insured patients. Uninsured patients should contact Tolmar's patient assistance program directly.

Pharmacy Options in West Virginia

Retail pharmacies like CVS, Walgreens, and Rite Aid can dispense Jatenzo but may not keep it in stock. Brand-name oral testosterone undecanoate is a low-volume product at most retail locations, meaning your pharmacist may need 2 to 5 business days to order it from their wholesaler.

Specialty pharmacies are a faster route. Several national specialty pharmacies licensed to ship into West Virginia maintain Jatenzo inventory. These pharmacies also handle prior authorization paperwork on your behalf.

503A compounding pharmacies: West Virginia-licensed 503A compounding pharmacies can compound oral testosterone undecanoate capsules from bulk powder when a prescriber writes a patient-specific prescription. Compounded versions are not FDA-approved and are not bioequivalent to Jatenzo, but they cost significantly less, often $50 to $150 per month. The FDA's guidance on 503A compounding permits this practice when the compounding pharmacy operates under a valid patient-specific prescription and does not compound copies of commercially available products in normal circumstances [5]. Some prescribers and legal analysts interpret this as limiting 503A compounding of testosterone undecanoate to cases where the commercial product is unavailable or medically inappropriate for the patient.

Required Labs and Monitoring After Starting Jatenzo

Before the first dose, your provider should have on file: two morning total testosterone levels, CBC with hematocrit, comprehensive metabolic panel, fasting lipid panel, and PSA if age-appropriate. The Endocrine Society guideline also recommends a baseline bone density assessment for men with osteoporosis risk factors [3].

After starting Jatenzo, monitoring follows this timeline:

Month 1: Check total testosterone level (drawn 4 to 6 hours after the morning dose, per the Jatenzo prescribing information). The starting dose of 237 mg twice daily is adjusted based on this level. If testosterone is below 300 ng/dL, the dose increases to 316 mg twice daily. If above 1,050 ng/dL, the dose decreases to 158 mg twice daily [1].

Months 3 to 6: Repeat CBC with hematocrit. The FDA label for Jatenzo carries a boxed warning about the risk of major adverse cardiovascular events, and hematocrit elevation above 54% is a threshold for dose reduction or discontinuation [1]. Repeat lipid panel, as oral testosterone undecanoate can increase LDL and decrease HDL.

Annually: Total testosterone, CBC, lipid panel, hepatic function, PSA. Bone density if indicated. The AUA guideline recommends annual reassessment of treatment goals and symptom response [4].

Patients on Jatenzo should also undergo blood pressure monitoring. In the Swerdloff trial, systolic blood pressure increased by a mean of 3 to 5 mmHg compared to baseline, and the FDA required a REMS (Risk Evaluation and Mitigation Strategy) at the time of initial approval, though the REMS was later modified [6].

Jatenzo vs. Injectable Testosterone: Clinical Comparison

Most men diagnosed with hypogonadism in West Virginia currently receive testosterone cypionate injections, typically 100 to 200 mg intramuscularly every 1 to 2 weeks. The cost difference is stark: generic testosterone cypionate runs $30 to $75 per month, while Jatenzo at list price costs roughly ten times more.

The clinical tradeoff favors Jatenzo in specific scenarios. Men who experience rollercoaster symptoms (energy spikes after injection followed by troughs before the next dose) may benefit from the more stable pharmacokinetics of twice-daily oral dosing. Men with needle phobia, bleeding disorders, or occupational restrictions that make injections impractical are also good candidates.

In terms of efficacy, the Swerdloff et al. trial showed that Jatenzo normalized testosterone in 87% of subjects [2], comparable to the 75 to 96% normalization rates reported in studies of testosterone cypionate and enanthate. The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine, examined cardiovascular safety of transdermal testosterone gel rather than Jatenzo specifically, but its findings that testosterone replacement did not increase major adverse cardiovascular events in men with preexisting or high risk of cardiovascular disease have informed prescribing confidence across all TRT formulations [7].

Timeline: From First Lab Draw to First Dose

For a West Virginia patient using telehealth, the typical timeline looks like this:

• Day 1: Order labs through your telehealth platform. Walk into a draw site.
• Days 3 to 5: Lab results return. Schedule or complete your clinical evaluation.
• Days 5 to 7: Prescriber reviews results, confirms diagnosis, writes prescription.
• Days 7 to 14: Pharmacy receives Rx, processes prior authorization if needed, ships medication.
• Days 10 to 21: First dose.

Without insurance complications, the entire process can finish in under two weeks. PA delays can add 5 to 15 business days. Patients who self-pay and use a specialty pharmacy with Jatenzo in stock sometimes receive their medication within 5 to 7 days of the initial lab draw.

Transferring a Jatenzo Prescription to West Virginia

If you already have an active Jatenzo prescription from another state, your out-of-state prescriber cannot simply transfer the Rx to a WV pharmacy. Controlled substance prescriptions in Schedule III through V can be transferred between pharmacies in different states, but the receiving pharmacy must be licensed in West Virginia, and the transfer must comply with DEA regulations (21 CFR §1306.25). Each prescription can be transferred only once unless it is maintained in a shared real-time online database between the pharmacies.

The simpler path: establish care with a WV-licensed prescriber (via telehealth or in person), share your prior lab work and treatment history, and have them write a new prescription. Most telehealth platforms can onboard an existing TRT patient within one visit.